Safety first : evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Future oncology (London, England) - 16(2020), 20 vom: 14. Juli, Seite 1409-1411 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sean Ong, Xuan Rui [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ADT |
|---|
| Anmerkungen: |
Date Completed 13.07.2020 Date Revised 10.01.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/fon-2020-0388 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309899575 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309899575 | ||
| 003 | DE-627 | ||
| 005 | 20231225134922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/fon-2020-0388 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1032.xml |
| 035 | |a (DE-627)NLM309899575 | ||
| 035 | |a (NLM)32407145 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sean Ong, Xuan Rui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Safety first |b evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.07.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a ADT | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a androgen deprivation therapy | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a hormonal therapy | |
| 650 | 4 | |a prostate | |
| 650 | 4 | |a prostatectomy | |
| 650 | 4 | |a surgery | |
| 650 | 4 | |a urologic | |
| 650 | 7 | |a Androgen Antagonists |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents, Hormonal |2 NLM | |
| 700 | 1 | |a Condon, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Bagguley, Dominic |e verfasserin |4 aut | |
| 700 | 1 | |a Lawrentschuk, Nathan |e verfasserin |4 aut | |
| 700 | 1 | |a Azad, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Declan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future oncology (London, England) |d 2005 |g 16(2020), 20 vom: 14. Juli, Seite 1409-1411 |w (DE-627)NLM161450725 |x 1744-8301 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2020 |g number:20 |g day:14 |g month:07 |g pages:1409-1411 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/fon-2020-0388 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2020 |e 20 |b 14 |c 07 |h 1409-1411 | ||